ROTOP Pharmaka is a leading pharmaceutical company in the field of nuclear medicine and molecular imaging. In our production building at Helmholtz-Center Dresden-Rossendorf, radiopharmaceuticals are manufactured in two clean room facilities for nuclear medicine diagnostics of functional disorders and for oncology investigations.

Jens Junker has been Managing Director and CEO of ROTOP Pharmaka and ROTOP Radiopharmacy since September 2014. He is supported by Dr. Wilhelm Zörgiebel, main shareholder of ROTOP.

The extended management includes Dr. Antje Sterger (ppa.) as Chief Operating Officer.

Over 20 Years of Experience

Our roots go back to 1958 with the production of radioactive materials in the Central Institute for Nuclear Research in Rossendorf. Since then, we have developed into one of the leading radiopharmaceutical centres in the world – today known as Radiopharmaceutical Valley.

Our Team

Further Business Units

Manufacturing, distribution and logistics of ready-to-use radiopharmaceuticals and radiochemicals

Comprehensive services in the field of Contract Development and Manufacturing